S. Shapiro

3.5k total citations
65 papers, 2.3k citations indexed

About

S. Shapiro is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, S. Shapiro has authored 65 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Public Health, Environmental and Occupational Health and 15 papers in Genetics. Recurrent topics in S. Shapiro's work include Cancer Risks and Factors (11 papers), Estrogen and related hormone effects (10 papers) and Global Cancer Incidence and Screening (8 papers). S. Shapiro is often cited by papers focused on Cancer Risks and Factors (11 papers), Estrogen and related hormone effects (10 papers) and Global Cancer Incidence and Screening (8 papers). S. Shapiro collaborates with scholars based in United States, South Africa and Australia. S. Shapiro's co-authors include Lynn Rosenberg, David W. Kaufman, Carol Louik, Judith P. Kelly, Allen A. Mitchell, Martha M. Werler, Catherine Hayes, Julie R. Palmer, Olli P. Heinonen and Manfred Dietel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

S. Shapiro

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Shapiro United States 25 559 437 362 336 324 65 2.3k
Rita Schinnar United States 21 302 0.5× 206 0.5× 379 1.0× 214 0.6× 356 1.1× 36 2.5k
Joel Neugarten United States 40 528 0.9× 279 0.6× 584 1.6× 786 2.3× 409 1.3× 82 4.6k
Sandra C. Hoffman United States 32 658 1.2× 611 1.4× 409 1.1× 194 0.6× 99 0.3× 54 3.3k
B Westerholm Sweden 22 382 0.7× 221 0.5× 700 1.9× 419 1.2× 335 1.0× 73 3.8k
Laura E. Derby United States 24 449 0.8× 174 0.4× 274 0.8× 629 1.9× 149 0.5× 29 2.5k
Ji‐Yeob Choi South Korea 35 640 1.1× 756 1.7× 459 1.3× 183 0.5× 210 0.6× 131 3.6k
Susan Nayfield United States 22 433 0.8× 681 1.6× 210 0.6× 111 0.3× 92 0.3× 35 2.7k
Judith K. Jones United States 28 109 0.2× 324 0.7× 294 0.8× 140 0.4× 328 1.0× 120 3.2k
W.H. Linda Kao United States 37 592 1.1× 198 0.5× 513 1.4× 1.1k 3.3× 256 0.8× 83 4.7k
L Wibell Sweden 31 875 1.6× 188 0.4× 171 0.5× 1.1k 3.3× 270 0.8× 111 3.3k

Countries citing papers authored by S. Shapiro

Since Specialization
Citations

This map shows the geographic impact of S. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Shapiro more than expected).

Fields of papers citing papers by S. Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Shapiro. The network helps show where S. Shapiro may publish in the future.

Co-authorship network of co-authors of S. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of S. Shapiro. A scholar is included among the top collaborators of S. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Shapiro. S. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, S., T. J. de Villiers, Amos Pines, et al.. (2014). Risks and benefits of hormone therapy: has medical dogma now been overturned?. Climacteric. 17(3). 215–222. 13 indexed citations
2.
Pines, Amos, S. Shapiro, & Samy Suissa. (2012). NNT, number needed to treat: does it have any real value?. Climacteric. 15(2). 139–142. 4 indexed citations
3.
Katz, Alan R., Olusegun O. Soge, Glenn M. Wasserman, et al.. (2011). Neisseria gonorrhoeae With High-Level Resistance to Azithromycin: Case Report of the First Isolate Identified in the United States. Clinical Infectious Diseases. 54(6). 841–843. 79 indexed citations
4.
Shapiro, S.. (2008). Oral contraceptives, hormone therapy and cardiovascular risk. Climacteric. 11(5). 355–363. 15 indexed citations
5.
Shapiro, S.. (2007). False alarm: postmenopausal hormone therapy and ovarian cancer. Climacteric. 10(6). 466–470. 8 indexed citations
6.
7.
Shapiro, S.. (2004). Effets du THS sur le risque de cancer du sein et de maladie cardiovasculaire : la validité des preuves épidémiologiques. Gynécologie Obstétrique & Fertilité. 32(5). 382–390. 6 indexed citations
8.
Hoffman, M. Timm, Diane Cooper, Henri Carrara, et al.. (2003). Limited Pap screening associated with reduced risk of cervical cancer in South Africa. International Journal of Epidemiology. 32(4). 573–577. 34 indexed citations
9.
Shapiro, S.. (2000). Bias in the Evaluation of Low-Magnitude Associations: An Empirical Perspective. American Journal of Epidemiology. 151(10). 939–945. 73 indexed citations
10.
Shapiro, S., Lynn Rosenberg, M. Timm Hoffman, et al.. (2000). Risk of Breast Cancer in Relation to the Use of Injectable Progestogen Contraceptives and Combined Estrogen/Progestogen Contraceptives. American Journal of Epidemiology. 151(4). 396–403. 67 indexed citations
11.
Shapiro, S., Surapol Issaragrisil, David W. Kaufman, et al.. (1999). Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.. American Journal of Tropical Medicine and Hygiene. 60(4). 573–577. 50 indexed citations
12.
Issaragrisil, Surapol, David W. Kaufman, Kanchana Chansung, et al.. (1997). Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology. 25(5). 1255–1257. 15 indexed citations
13.
Kaufman, David W., Judith P. Kelly, Theresa Anderson, David C. Harmon, & S. Shapiro. (1997). Evaluation of Case Reports of Aplastic Anemia Among Patients Treated with Felbamate. Epilepsia. 38(12). 1265–1269. 97 indexed citations
14.
Kaufman, David W., Surapol Issaragrisil, Theresa Anderson, et al.. (1997). Use of household pesticides and the risk of aplastic anaemia in Thailand. The Aplastic Anemia Study Group. International Journal of Epidemiology. 26(3). 643–650. 14 indexed citations
15.
Shapiro, S., et al.. (1996). Alcohol-containing Mouthwashes and Oropharyngeal Cancer: A Spurious Association due to Underascertainment of Confounders?. American Journal of Epidemiology. 144(12). 1091–1095. 33 indexed citations
16.
Rosenberg, Lynn, Julie R. Palmer, R. Sowmya Rao, et al.. (1996). Case-Control Study of Oral Contraceptive Use and Risk of Breast Cancer. American Journal of Epidemiology. 143(1). 25–37. 43 indexed citations
17.
Zhang, Yuqing, Lynn Rosenberg, Theodore Colton, et al.. (1996). Adult Height and Risk of Breast Cancer among White Women in a Case-Control Study. American Journal of Epidemiology. 143(11). 1123–1128. 14 indexed citations
18.
Werler, Martha M., Carol Louik, S. Shapiro, & Allen A. Mitchell. (1994). Ovulation induction and risk of neural tube defects. The Lancet. 344(8920). 445–446. 13 indexed citations
19.
Lévy, M, Judith P. Kelly, David W. Kaufman, & S. Shapiro. (1993). Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: A report from the international agranulocytosis and aplastic anemia study. Annals of Hematology. 67(4). 187–190. 13 indexed citations
20.
Rosenberg, Lynn, Julie R. Palmer, Judith P. Kelly, David W. Kaufman, & S. Shapiro. (1988). COFFEE DRINKING AND NONFATAL MYOCARDIAL INFARCTION IN MEN UNDER 55 YEARS OF AGE1. American Journal of Epidemiology. 128(3). 570–578. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Schinnar Breakdown of academic impact, for papers by Joel Neugarten Breakdown of academic impact, for papers by Sandra C. Hoffman Breakdown of academic impact, for papers by B Westerholm Breakdown of academic impact, for papers by Laura E. Derby Breakdown of academic impact, for papers by Ji‐Yeob Choi Breakdown of academic impact, for papers by Susan Nayfield Breakdown of academic impact, for papers by Judith K. Jones Breakdown of academic impact, for papers by W.H. Linda Kao Breakdown of academic impact, for papers by L Wibell
Rankless by CCL
2026